IOL CHEMICALS AND PHARMACEUTICALS
|
IOL CHEMICALS AND PHARMACEUTICALS Last 5 Year Cashflow Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | |
---|---|---|---|
Profit Before Tax | ₹182 Cr | ₹189 Cr | ₹225 Cr |
Adjustment | ₹60 Cr | ₹44 Cr | ₹33 Cr |
Changes In working Capital | ₹90 Cr | ₹-64 Cr | ₹-102 Cr |
Cash Flow after changes in Working Capital | ₹332 Cr | ₹169 Cr | ₹156 Cr |
Cash Flow from Operating Activities | ₹290 Cr | ₹122 Cr | ₹93 Cr |
Cash Flow from Investing Activities | ₹-191 Cr | ₹-120 Cr | ₹-121 Cr |
Cash Flow from Financing Activities | ₹-93 Cr | ₹-4.11 Cr | ₹-1.64 Cr |
Net Cash Inflow / Outflow | ₹6.30 Cr | ₹-1.84 Cr | ₹-29 Cr |
Opening Cash & Cash Equivalents | ₹1.39 Cr | ₹3.23 Cr | ₹32 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - |
Closing Cash & Cash Equivalent | ₹7.69 Cr | ₹1.39 Cr | ₹3.23 Cr |
Compare Cashflow Statement of peers of IOL CHEMICALS AND PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
IOL CHEMICALS AND PHARMACEUTICALS | ₹2,222.7 Cr | -12.5% | -9.3% | -12.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,936.0 Cr | -5.8% | -3.2% | 35.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,157.0 Cr | -2.8% | -3.6% | 44.7% | Stock Analytics | |
CIPLA | ₹116,200.0 Cr | -3.9% | -0.5% | 13.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,325.0 Cr | -1.2% | 7.1% | 17.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,037.4 Cr | -2.7% | -0.1% | 40.9% | Stock Analytics |
IOL CHEMICALS AND PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
IOL CHEMICALS AND PHARMACEUTICALS | -12.5% |
-9.3% |
-12.9% |
SENSEX | -2.1% |
-6.4% |
7% |
You may also like the below Video Courses